Eli Lilly and Co (LLY)
733.51
+8.64
(+1.19%)
USD |
NYSE |
Apr 26, 16:00
733.50
-0.01
(-0.00%)
After-Hours: 20:00
Eli Lilly Gross Profit (TTM): 27.04B for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 27.04B |
September 30, 2023 | 25.23B |
June 30, 2023 | 22.95B |
March 31, 2023 | 21.51B |
December 31, 2022 | 21.91B |
September 30, 2022 | 22.11B |
June 30, 2022 | 22.09B |
March 31, 2022 | 21.82B |
December 31, 2021 | 21.01B |
September 30, 2021 | 20.78B |
June 30, 2021 | 19.85B |
March 31, 2021 | 19.34B |
December 31, 2020 | 19.06B |
September 30, 2020 | 18.17B |
June 30, 2020 | 18.06B |
March 31, 2020 | 18.29B |
December 31, 2019 | 17.60B |
September 30, 2019 | 17.27B |
June 30, 2019 | 17.13B |
March 31, 2019 | 16.97B |
December 31, 2018 | 16.81B |
September 30, 2018 | 15.63B |
June 30, 2018 | 15.54B |
March 31, 2018 | 15.44B |
December 31, 2017 | 15.53B |
Date | Value |
---|---|
September 30, 2017 | 16.44B |
June 30, 2017 | 16.16B |
March 31, 2017 | 15.85B |
December 31, 2016 | 15.51B |
September 30, 2016 | 15.26B |
June 30, 2016 | 15.19B |
March 31, 2016 | 15.01B |
December 31, 2015 | 14.92B |
September 30, 2015 | 14.80B |
June 30, 2015 | 14.69B |
March 31, 2015 | 14.67B |
December 31, 2014 | 14.68B |
September 30, 2014 | 15.24B |
June 30, 2014 | 16.20B |
March 31, 2014 | 17.22B |
December 31, 2013 | 18.20B |
September 30, 2013 | 18.49B |
June 30, 2013 | 18.16B |
March 31, 2013 | 17.85B |
December 31, 2012 | 17.81B |
September 30, 2012 | 17.82B |
June 30, 2012 | 18.39B |
March 31, 2012 | 18.96B |
December 31, 2011 | 19.22B |
September 30, 2011 | 19.45B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
17.13B
Minimum
Jun 2019
27.04B
Maximum
Dec 2023
20.59B
Average
20.78B
Median
Sep 2021
Gross Profit (TTM) Benchmarks
Amgen Inc | 19.74B |
Madrigal Pharmaceuticals Inc | -- |
Vertex Pharmaceuticals Inc | 8.607B |
Viking Therapeutics Inc | -- |
Moderna Inc | 2.061B |